Previous 10 | Next 10 |
TAMPA, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited net product sales. EXPAREL ® (bupivacaine liposome inj...
TAMPA, Fla., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced that it has filed a lawsuit in the United States District Court for the District of ...
The following slide deck was published by Pacira BioSciences, Inc. in conjunction with their 2021 Q3 earnings call. For further details see: Pacira BioSciences, Inc. 2021 Q3 - Results - Earnings Call Presentation
Pacira BioSciences, Inc. (PCRX) Q3 2021 Earnings Conference Call November 3, 2021 08:30 AM ET Company Participants Susan Mesco - IR Dave Stack - Chairman and CEO Charlie Reinhart - CFO Ronald Ellis - Senior Vice President Conference Call Participants David Amsellem - Piper Sandler Gregory Ren...
Image source: The Motley Fool. Pacira BioSciences, inc (NASDAQ: PCRX) Q3 2021 Earnings Call Nov 3, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Pacira BioSciences, inc (PCRX) Q3 2021 Earnings Call Transcript
Pacira BioSciences (NASDAQ:PCRX): Q3 Non-GAAP EPS of $0.72 beats by $0.07; GAAP EPS of $0.39 beats by $0.07. Revenue of $127.72M (+8.7% Y/Y) misses by $1.97M. Press Release Adjusted EBITDA was $48.1 million in the third quarter of 2021, compared to $34.2 million in the third quarter of 2020. ...
-- Third quarter GAAP net income of $17.7 million and adjusted EBITDA of $48.1 million -- -- Conference call today at 8:30 a.m. ET -- TAMPA, Fla., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid p...
AAWW, ACLS, ACRE, AGIO, AMRN, AMRX, ATH, ATY, AUPH, AUTL, AVA, BCRX, BDC, BDSI, BGCP, BIP, OTCPK:BMWYY, BR, BRSP, BWA, CDW, CIM, CIO, CLH, CLVS, CPRI, CRL, CRTO, CSTE, CTRA, CVE, CVS, CWH, DFIN, DISCA, OTCQX:DLAKF, OTCPK:DNNGY, DNOW, EAT, EMR, ES, ETR, EVRG, EVRI, EXC, EXPI, EYPT, FDP, FUN, F...
Pacira BioSciences (NASDAQ:PCRX) is scheduled to announce Q3 earnings results on Wednesday, November 3rd, before market open. The consensus EPS Estimate is $0.65 (-4.4% Y/Y) and the consensus Revenue Estimate is $129.69M (+10.4% Y/Y). Over the last 2 years, PCRX has beaten EPS estimates 88% o...
Pacira BioSciences (NASDAQ:PCRX) has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for claims of chemical composition of Exparel (bupivacaine liposome injectable suspension). After issuance, Pacira will submit the patent for listing in the FDA...
News, Short Squeeze, Breakout and More Instantly...
Pacira BioSciences Inc. Company Name:
PCRX Stock Symbol:
NASDAQ Market:
Pacira BioSciences Inc. Website:
TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results after the close of the U.S. markets on Tuesday July 30, 2024. Following the release, the company will host a live conference call and webc...
-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule implements the NOPAIN Act, signed into law as part of the Cons...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 86.1% to $0.514 on volume of 587,366,807 shares NVIDIA Corporation (NVDA) fell 1.3% to $122.67 on volume of 214,038,378 shares Tesla Inc. (TSLA) rose 10.2% to $231.26 on volume of 201,850,947 ...